Ehlers-Danlos Syndrome Gene Mutation Panel, NGS
Aortic Dysfunction or Dilation panel detects mutation or pathogenic variants in genes associated with aortopathy. These disorders are characterized by progressive aortic dilation, dissection, and other vascular findings, that may involve multiple organ systems. Progressing aortic dilatation increases the susceptibility to develop aortic aneurysms and aortic dissections. Pathogenic variants in genes associated with aortopathy lead to structurally weakened cardiac, vascular, and/or connective tissues that become prone to aneurysm dilatation, dissection, and/or rupture. Malformations of the heart, dysmorphic features, joint and skin laxity, and skeletal defects may also occur depending on the gene involved. Aortopathy may occur in the context of a recognizable genetic syndrome (Marfan syndrome or Loeys-Dietz syndrome) or with few to no additional clinical findings (a group of disorders known as familial thoracic aortic aneurysm and dissection or Familial TAAD). Identification of a patient’s underlying genetic mutation can have significant implications for monitoring and management.
The panel consists of 20 genes that have been associated with syndromic and non-syndromic forms of thoracic aortic aneurysm and dissection (TAAD). Complications from these disorders can occur at any age, and the presentation can be extremely variable. Inheritance is most often autosomal dominant with incomplete penetrance, but some forms of familial TAAD appear to follow an autosomal recessive pattern. Syndromic conditions that include the potential for aortic dysfunction include the following: Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome, osteogenesis imperfecta, congenital contractural arachnodactyly, Shprintzen-Goldberg syndrome, and arterial tortuosity syndrome. Molecular testing is useful to confirm the diagnosis and to identify the disease-causing mutation within a family to allow for carrier testing and prenatal diagnosis.
Non syndromic TAAD:
Thoracic aortic aneurysm and dissection (TAAD)
Familial TAAD describes those with TAAD who have absence of a known syndrome (e.g., Marfan syndrome, vEDS, LDS) and have a positive family history of TAAD. Familial thoracic aortic aneurysm and dissection (familial TAAD) is a genetically heterogeneous group of disorders characterized by aortic dilatation, aortic aneurysms, aortic dissection, and aneurysms of the other arteries (i.e. abdominal, cerebral). In addition to cardiac defects, TAAD can manifest with other features including: congenital heart abnormalities, inguinal hernia, scoliosis, a purplish skin discoloration (livedo reticularis) caused by abnormalities in the tiny blood vessels of the skin, or ocular abnormalities (i.e. iris flocculi). Generally, the first feature to present is aortic dilatation, where the aorta is stretched and weakened over time. This dilatation increases the susceptibility to develop aortic aneurysms and aortic dissection. Aortic dissection occurs when a tear in the aorta wall results in bleeding into and along the wall of the aorta. These dissections primarily originate in the ascending aorta (Stanford type A), but also can occur in the descending thoracic aorta (Stanford type B). Familial TAAD is accounts for about 20% of all cases of thoracic aortic aneurysms and dissections. They may have a causative pathogenic variant identified in one of the 16 known Familial TAAD-related genes (ACTA2, BGN, COL3A1, FBN1, FOXE3, LOX, MAT2A, MFAP5, MYH11, MYLK, PRKG1, TGFB2, TGFB3, TGFBR1, TGFBR2, SMAD3).
Syndromic TAAD:
Marfan syndrome (MFS)
MFS is an autosomal dominant disorder of connective tissue, with a high degree of clinical variability. Major features involve the musculoskeletal, cardiovascular, and ocular systems. Approximately 70-93% of people meeting diagnostic criteria for Marfan syndrome have mutations in FBN1, which encodes the protein fibrillin-1, an extracellular matrix protein that contribute to microfibril formation in elastic and non elastic tissues. Aortic dilation (commonly at the level of the sinuses of Valsalva) is common and can result in dissection, although presentation and age of onset is variable, and dilation may be mild or absent in some individuals. Ectopia lentis (lens dislocation) is a characteristic feature of Marfan syndrome and is present in approximately 60% of affected individuals. Other characteristic clinical findings include aortic root dilation, pulmonary emphysema, atrioventricular valve changes and skeletal muscle myopathy. Symptoms typically worsen over time. Infants who present with symptoms typically have the most severe disease course.
Loeys-Dietz syndrome (LDS)
LDS is an autosomal dominant disorder that affects many parts of the body. LDS is mostly caused by mutations in either the TGFBR1 (20%) or TGFBR2 (60%). However, a small percentage of people with LDS may have mutations in SMAD2 (5%), SMAD3 (5%), TGFB2 (5%), or TGFB3 (5%). The common TGFBR2 mutations that cause Loeys-Dietz syndrome change a single amino acid in the TGF-β receptor type 1, resulting in a receptor with little or intracellular signaling capability. It is believed that a lack of normal TGF-β signaling pathway results in abnormal compensatory mechanisms that increase intracellular signaling and disrupts the development of connective tissue in various organs and leads to the varied signs and symptoms of Loeys-Dietz syndrome type I. Major manifestations of this condition include vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula/ cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS may also demonstrate a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease.
Vascular Ehlers-Danlos syndrome (vEDS or EDS type IV)
EDS type IV is an autosomal dominant condition caused by mutations in the COL3A1 gene. These mutations alter the structure of type III collagen that leads to intracellular storage and impaired secretion of collagen chains. Therefore, this disorder affects the connective tissues that support the skin, bones, blood vessels, and most other organs and tissues. Lack of normal collagen support results in an increased risk of organ rupture, including tearing of the intestine and rupture of the uterus during pregnancy. Other features include arterial, intestinal, and/or uterine fragility; thin, translucent skin; easy bruising; characteristic facial appearance (thin vermilion of the lips, micrognathia, narrow nose, prominent eyes), and an aged appearance to the extremities, particularly of the hands. Many adults present with the following symptoms: vascular dissection or rupture, gastrointestinal perforation, or organ rupture. Infants and children may present with congenital dislocation of the hips, clubfoot, pneumothorax, and/or recurrent joint subluxation or dislocation. Vascular Ehlers-Danlos syndrome has an estimated the prevalence of 1/150 000.
Arterial tortuosity syndrome
This is a rare autosomal recessive connective tissue disorder characterized by tortuosity and elongation of the large and medium-sized arteries and a propensity towards aneurysm formation, vascular dissection, and stenosis of the aorta and/or pulmonary arteries. The disease is caused by loss-of-function mutations in the SLC2A10 gene (20q13.12), encoding the glucose/dehydroascorbic acid transporter 10 (GLUT10). GLUT10 acts as an intracellular transporter of dehydroascorbic acid and the resulting shortage of ascorbate might impair collagen and elastin crosslinking in the endoplasmic reticulum, redox homeostasis in the mitochondria and global gene-specific methylation/hydroxymethylation affecting the epigenetic regulation in the nucleus. Onset usually occurs in infancy or early childhood and the clinical manifestations are variable, depending on the arteries affected. The cardiovascular anomalies may lead to right ventricular hypertension, acute respiratory symptoms, ventricular hypertrophy and cardiac failure. Patients are prone to aneurysm formation, dissection and ischemic events. Other manifestations include facial dysmorphism (features variably include an long face, hypertelorism, down slanting palpebral fissures, beaked nose, sagging cheeks, a high palate, and micrognathia), soft and hyperextensible skin, hernias (inguinal, diaphragmatic, or hiatal), skeletal abnormalities, joint hypermobility, congenital contractures, keratoconus and generalized hypotonia.
Panel Components
Although it depends on the laboratory and the clinical utility this panel uses targeted next-generation sequencing to evaluate for most common variants within genes: ACTA2, CBS, COL1A1, COL3A1, COL5A1, COL5A2, ELN, FBLN5, PLOD1, FBN1, FBN2, MYH11, MYLK, NOTCH1, SKI, SLC2A10, SMAD3, TGFB2, TGFBR1, and TGFBR2 associated with Aortic Dysfunction or Dilation disorders.
- Genetic evaluation for patients with a personal or family history suggestive of Marfan syndrome, Loeys-Dietz syndrome, thoracic aortic aneurysm and dissections, or a related disorder
- For confirmation of clinical diagnosis in symptomatic patients suggestive of Marfan syndrome, Loeys-Dietz syndrome, thoracic aortic aneurysm and dissections, or a related disorder
- Differential diagnosis of familial TAAD, Marfan syndrome, Loeys-Dietz syndrome and phenotypically related disorders
- Identifying variants within genes known to be associated with increased risk for aneurysms and other disease features allowing for predictive testing of at-risk family members
Depending in variation (been small intragenic deletions/insertions and missense, nonsense, and splice site variants) if pathogenic and if associated with or loss or decreased function of the phenotype related to disease will be more indicative or diagnostic. Simply, the evidence must support a pathogenic classification of genes variation (mutation) tested to be diagnostic or prognostic as well as therapy target.
Note: some of the gene variants tested by this panel may have more than one associated phenotype changes and/or inheritance pattern. In contrast, some genetic variants may have reduced penetrance and/or variable expressivity in some phenotypic individuals.
The sequencing and deletion/duplication results for all genes on this panel are negative
Whole blood (EDTA), buccal swab (alternative).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Gene. 2019;707: 151-171. Review. [PMID: 31075413]
- J Biotechnol. 2019;301: 105-111. [PMID: 31163209]
- Genet 2010;87(5):701-707. [PMID: 21055718]
- J Vasc Surg. 2018;68: 225-233.e5. [PMID: 28847661]
- Engl J Med 2006 Aug 24;355(8):788-798. [PMID: 16928994]
- Nat Genet 2007 Dec;39(12):1488-1493. [PMID: 17994018]
- Int J Cardiol. 2017 Jan 1;226:21-25. [PMID: 27780078]
- Genet. Med. 2017;19: 386-395 [PMID: 27632686]
- Circ Cardiovasc Genet. 2016;9: 548-558. [PMID: 27879313]
- Hum. Mutat. 2015;36: 1145-9 [PMID: 26247899]
- Trans Am Clin Climatol Assoc. 2014;125: 300-12. [PMID: 25125747]
- Curr Atheroscler Rep. 2012;14:219-26. [PMID: 22415348]
- Curr Med Chem. 2012;19: 454-60. [PMID: 22335518]
- Milewicz DM, Regalado E. Thoracic Aortic Aneurysms and Aortic Dissections. 2003 Feb 13 [Updated 2012 Jan 12]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.